lupus and tirzepatide Is safe for patients? GLP-1 Agonists in Autoimmune Disease

MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function

4 Combinations of GIP receptor targeting treatments and GLP-1 receptor agonism In recent years, GIP receptor agonists and antagonists have gained attention for their therapeutic potential in treating obesity and type 2 diabetes

I was so shocked

A recent post by Dr

Does GLP-1 make you tired

While bimagrumab has shown promise as a safe pharmacological intervention for enhancing muscle mass and reducing fat mass in sarcopenia, its minimal effects on muscle strength and broader physical performance to date have introduced a note of caution